Check patentability & draft patents in minutes with Patsnap Eureka AI!

Preparation method of a mesoporous manganese dioxide nanometer drug-loading system with photodynamic therapy switching effect and molecular recognition

A photodynamic therapy and switching effect technology, applied in the field of medicine, can solve the problems of reducing the killing effect of reactive oxygen species, difficult metabolism and removal of photosensitizers, and difficulty in small molecule photosensitizers, achieving rich raw materials, avoiding photosensitivity toxicity, facilitating treatment and The effect of the patient's health

Active Publication Date: 2020-01-14
ZHENGZHOU UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, there are still some problems in photodynamic therapy at present. Most photosensitizers such as HMME are water insoluble drugs, which are difficult to be directly applied in the body; Efficient distribution of tumor cells, subcellular organelles); tumor cells have a certain oxidative stress regulation effect, reducing the killing effect of active oxygen;
[0006] More importantly, in previous studies, it was found that commonly used photosensitizers such as HMME and CE6 are difficult to be metabolized and cleared in the body, and accumulate in large quantities in the body, resulting in severe photosensitivity toxicity. Toxicity, the patient needs to be completely protected from light for about 4 weeks, which undoubtedly brings great pain to the patient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of a mesoporous manganese dioxide nanometer drug-loading system with photodynamic therapy switching effect and molecular recognition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] In the specific implementation of the present invention, a method for preparing a mesoporous manganese dioxide nano-loading system with photodynamic therapy switching effect and molecular recognition, the preparation of mesoporous MnO 2 For nanoparticles, put 2.5g of sodium dodecylbenzenesulfonate (SDBS) into an EP tube, add 18ml of ultrapure water to dissolve, stir at 70°C for 15min, add 1.5g of KMnO 4 In 18ml of ultrapure aqueous solution, stir at 70°C for 15min, then add 6ml of 2mol / L nitric acid solution dropwise, stir and react at 70°C for 3h, wash with water or ethanol until neutral, centrifuge at 12000r / min for 10min, precipitate and dry at 250°C Calcined for 3h to form mesoporous MnO 2 nanoparticles;

[0018] (2), loading photosensitizer hematoporphyrin monomethyl ether (HMME): take 2ml of hematoporphyrin monomethyl ether (HMME) methanol solution of 2mg / ml and place it in a round bottom flask, then add 1mg / ml of mesoporous MnO 2 Nanoparticle methanol solution ...

Embodiment 2

[0022] In the specific implementation of the present invention, a method for preparing a mesoporous manganese dioxide nano-loading system with photodynamic therapy switching effect and molecular recognition, the preparation of mesoporous MnO 2 Nanoparticles: Dissolve 2g of sodium dodecylbenzenesulfonate (SDBS) in 16ml of ultrapure water, stir at 70°C for 15min, add 1.2g of KMnO 4 In 16ml of ultrapure aqueous solution, stir at 70°C for 15min, then add 6ml of 2mol / L nitric acid solution dropwise, stir and react at 70°C for 3h, wash with water or ethanol until neutral, centrifuge at 12000r / min for 10min, precipitate and dry at 250°C Calcined for 3h to form mesoporous MnO 2 nanoparticles.

Embodiment 3

[0024] In the specific implementation of the present invention, a method for preparing a mesoporous manganese dioxide nano-loading system with photodynamic therapy switching effect and molecular recognition, the preparation of mesoporous MnO 2 Nanoparticles: Dissolve 1.8g of sodium dodecylbenzenesulfonate (SDBS) in 19ml of ultrapure water, stir at 70°C for 15min, add 1.8g of KMnO 4 In 19ml of ultrapure aqueous solution, stir at 70°C for 15min, then add 6ml of 2mol / L nitric acid solution dropwise, stir and react at 70°C for 3h, wash with water or ethanol until neutral, centrifuge at 12000r / min for 10min, precipitate and dry at 250°C Calcined for 3h to form mesoporous MnO 2 nanoparticles.

[0025] The preparation method of the present invention is simple, easy to produce, low in cost and good in use effect, and its product can be effectively used in photodynamic therapy of tumors, and realizes the mesoporous manganese dioxide nanometer drug-carrying system with photodynamic the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a preparation method for a mesoporous manganese dioxide nanometer drug delivery system with photodynamic therapy switch effect and molecular recognition effect. The mesoporousmanganese dioxide nanometer drug delivery system can effectively overcome medication problems in photodynamic therapy of tumors. The preparation method comprises the following steps: dissolving sodium dodecyl benzene sulfonate and KMnO4 in ultrapure water, adding a nitric acid solution, carrying out centrifugation, and drying and calcining a precipitate so as to obtain mesoporous MnO2 nanoparticles; weighing a methanol solution of hematoporphyrin monomethyl ether, adding methanol solution of the mesoporous MnO2 nanoparticles, and successively carrying out uniform mixing, ultrasonic treatmentand spin-drying so as to obtain mesoporous MnO2 nanoparticles loaded with the photosensitizer hematoporphyrin monomethyl ether; weighing ssDNA 5'-HS-TTTCCCAGTTGATCCTTTGGATACCCTGGG and preparing hairpin nucleic acid aptamers; and adding the aptamers into the mesoporous MnO2 nanoparticles loaded with the photosensitizer hematoporphyrin monomethyl ether for a reaction to allow as many aptamers as possible to be immobilized onto the surfaces of the mesoporous MnO2 nanoparticles loaded with the photosensitizer hematoporphyrin monomethyl ether. The method of the invention is simple in process, easyto operate, rich in raw materials, low in cost, good in use effect, and capable of preventing the photosensitivity of PDT.

Description

technical field [0001] The invention relates to medicine, in particular to a preparation method of a mesoporous manganese dioxide nano drug-carrying system with photodynamic therapy switch effect and molecular recognition function. Background technique [0002] Tumor is a disease that seriously threatens human health and is difficult to cure. Currently, the main treatments for tumors include surgery, chemotherapy and radiotherapy. Since the 1990s, tumor photodynamic therapy has become a research hotspot, mainly focusing on the tumor-specific transport of photosensitizers, the mechanism of photodynamic therapy on tumors, and its synergistic effect with other treatments. [0003] The mechanism of tumor photodynamic therapy is also an important direction of tumor photodynamic therapy. Due to the very limited lifespan and movement distance of reactive oxygen species (ROS) generated in photodynamic therapy, only 20nS, 200nm, most ROS do not cause damage to the effective parts of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/02A61K41/00A61K47/26A61P35/00
CPCA61K41/0071A61K47/02A61K47/26
Inventor 张振中庄路阳史进进刘卫张慧芳安静一赵秀
Owner ZHENGZHOU UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More